Scribe Biosciences Overview
- Year Founded
-
2017
- Status
-
Out of Business
- Employees
-
4
- Latest Deal Type
-
Out of Business
- Investors
-
1
Scribe Biosciences General Information
Description
Developer of single-cell analysis tools designed to provide development in clinical and research applications. The company's tools use printed droplet microfluidics to perform picoliter-scale manipulations by leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, enabling doctors to gain knowledge and develop studies for processes in infectious cancer diseases.
Contact Information
Website
www.scribebiosciences.comCorporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Corporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Scribe Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Out of Business | 12-Feb-2025 | Completed | Generating Revenue | |||
| 12. Grant | 10-Aug-2023 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 22-May-2023 | Completed | Generating Revenue | |||
| 9. Grant | 07-Sep-2022 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 01-Dec-2021 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 01-May-2021 | Completed | Generating Revenue | |||
| 6. Grant | 07-Feb-2020 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2020 | $225K | Completed | Generating Revenue | ||
| 4. Grant | 01-Jan-2019 | $575K | Completed | Generating Revenue |
Scribe Biosciences Patents
Scribe Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023183461-A1 | Microfluidic cartridges | Inactive | 24-Mar-2022 | ||
| US-20230250468-A1 | Homogenous assays in microdroplets | Inactive | 18-Jan-2022 | ||
| US-20230016357-A1 | Deterministic hybridoma generation via microfluidics | Inactive | 10-Mar-2021 | ||
| US-20230159878-A9 | Deterministic hybridoma generation via microfluidics | Inactive | 10-Mar-2021 | ||
| US-20220106631-A1 | Barcoding in droplets for cell-cell interaction and secreted protein detection and analysis | Inactive | 05-Oct-2020 | C12Q1/6804 |
Scribe Biosciences Signals
Scribe Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| UCSF Innovation Ventures | Venture Capital | Minority |
Scribe Biosciences FAQs
-
When was Scribe Biosciences founded?
Scribe Biosciences was founded in 2017.
-
Where is Scribe Biosciences headquartered?
Scribe Biosciences is headquartered in San Francisco, CA.
-
What is the size of Scribe Biosciences?
Scribe Biosciences has 4 total employees.
-
What industry is Scribe Biosciences in?
Scribe Biosciences’s primary industry is Other Devices and Supplies.
-
Is Scribe Biosciences a private or public company?
Scribe Biosciences is a Private company.
-
What is Scribe Biosciences’s current revenue?
The current revenue for Scribe Biosciences is .
-
How much funding has Scribe Biosciences raised over time?
Scribe Biosciences has raised $250K.
-
Who are Scribe Biosciences’s investors?
UCSF Innovation Ventures has invested in Scribe Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process